Mundipharma GmbH
- A01 - Preparados estomatológicos
- BETAISODONA MUND-ANTISEPTIKUM mouth wash 10%
- D08 - Antisépticos y desinfectantes
- BETAISODONA cutaneous solution 10%
- BETAISODONA ointment 10%
- BETASEPTIC MUNDIPHARMA cutaneous solution 32.4 mg/ml
- REPITHEL gel
- D09 - Apósitos medicamentosos
- BETAISODONA impregnated dressing 300 mg
- H02 - Corticosteroides para uso sistémico
- LODOTRA prolonged-release tablet 1 mg
- LODOTRA prolonged-release tablet 2 mg
- LODOTRA prolonged-release tablet 5 mg
- L01 - Antineoplásicos
- HERZUMA powder for solution for infusion 150 mg
- HERZUMA powder for solution for infusion 420 mg
- LEVACT powder for solution for infusion 25 mg
- TRUXIMA concentrate for solution for infusion 100 mg/10 ml
- TRUXIMA MUNDIPHARMA concentrate for solution for infusion 500 mg/50 ml
- L03 - Inmunoestimulantes
- PELMEG IN EINER FERTIGSPRITZE solution for injection 6 mg/0.6 ml
- N02 - Analgésicos
- DHC MUNDIPHARMA prolonged-release tablet 120 mg
- DHC MUNDIPHARMA prolonged-release tablet 60 mg
- DHC MUNDIPHARMA prolonged-release tablet 90 mg
- MSI MUNDIPHARMA solution for injection 10 mg/1 ml
- MSI MUNDIPHARMA solution for injection 100 mg/5 ml
- MSI MUNDIPHARMA solution for injection 20 mg/1 ml
- MSI MUNDIPHARMA solution for injection 200 mg/10 ml
- MSR MUNDIPHARMA suppository 10 mg
- MSR MUNDIPHARMA suppository 20 mg
- MSR MUNDIPHARMA suppository 30 mg
- MST MUNDIPHARMA PB PHARMA prolonged-release tablet 60 mg
- MST MUNDIPHARMA prolonged-release tablet 10 mg
- MST MUNDIPHARMA prolonged-release tablet 100 mg
- MST MUNDIPHARMA prolonged-release tablet 200 mg
- MST MUNDIPHARMA prolonged-release tablet 30 mg
- MST MUNDIPHARMA prolonged-release tablet 60 mg
- MST prolonged-release granules 100 mg
- MST prolonged-release granules 20 mg
- MST prolonged-release granules 30 mg
- MST prolonged-release granules 60 mg
- OXYGESIC AKUT capsule, hard 10 mg
- OXYGESIC AKUT capsule, hard 20 mg
- OXYGESIC AKUT capsule, hard 5 mg
- OXYGESIC DISPERSA orodispersible tablet 10 mg
- OXYGESIC DISPERSA orodispersible tablet 20 mg
- OXYGESIC DISPERSA orodispersible tablet 5 mg
- OXYGESIC INFUSIO concentrate for solution for infusion 50 mg/1 ml
- OXYGESIC INJEKT concentrate for solution for injection 10 mg/1 ml
- OXYGESIC prolonged-release tablet 10 mg
- OXYGESIC prolonged-release tablet 20 mg
- OXYGESIC prolonged-release tablet 40 mg
- OXYGESIC prolonged-release tablet 5 mg
- OXYGESIC prolonged-release tablet 80 mg
- PALLADON capsule, hard 1.3 mg
- PALLADON capsule, hard 2.6 mg
- PALLADON prolonged-release capsule, hard 16 mg
- PALLADON prolonged-release capsule, hard 24 mg
- PALLADON prolonged-release capsule, hard 4 mg
- PALLADON prolonged-release capsule, hard 8 mg
- PALLADON REMEDIX prolonged-release capsule, hard 16 mg
- PALLADON solution for injection 10 mg/ml
- PALLADON solution for injection 100 mg/10 ml
- PALLADON solution for injection 2 mg/ml
- PALLADON solution for injection 20 mg/ml
- PALLADON solution for injection 50 mg/ml
- SEVREDOL film-coated tablet 20 mg
- SEVREDOL MUNDIPHARMA film-coated tablet 10 mg
- TARGIN prolonged-release tablet 10 mg+5 mg
- TARGIN prolonged-release tablet 20 mg+10 mg
- TARGIN prolonged-release tablet 40 mg+20 mg
- TARGIN prolonged-release tablet 5 mg+2.5 mg
- TARGIN prolonged-release tablet 60 mg+30 mg
- TARGIN prolonged-release tablet 80 mg+40 mg
- TRAMUNDIN prolonged-release tablet 100 mg
- N07 - Otros fármacos activos sobre el sistema nervioso
- SUBSTITOL prolonged-release capsule, hard 100 mg
- SUBSTITOL prolonged-release capsule, hard 200 mg
- SUBSTITOL prolonged-release capsule, hard 30 mg
- SUBSTITOL prolonged-release capsule, hard 60 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLUTIFORM K-HALER pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM K-HALER pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- FLUTIFORM pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- UNIPHYLLIN prolonged-release tablet 300 mg
- UNIPHYLLIN prolonged-release tablet 400 mg
- UNIPHYLLIN prolonged-release tablet 600 mg
- V03 - Todos los demás preparados terapéuticos
- NYXOID IM EINZELDOSISBEHÄLTNIS nasal spray, solution 1.8 mg